Ligand Reports Third Quarter 2021 Financial Results
Go back to Ligand Reports Third Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 268.00 +5.83 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $259.35 | 52 Week Low | $82.07 | |||
| Day High | $270.60 | P/E | 623.26 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 841,817 | |||||

